Clinical trial NCT06286852: Italian Language Validation of The Eating Disorder Examination (EDE) - Child Version
Official title: Italian Language Validation of The Eating Disorder Examination (EDE) - Child Version
Study type: OBSERVATIONAL
Overall status: ACTIVE_NOT_RECRUITING
Conditions: Feeding and Eating Disorders of Childhood
Lead sponsor: Meyer Children's Hospital IRCCS
Sponsor class: OTHER
First posted: 2024-02-29
Enrollment: 250
Sex: ALL
Minimum age (years): 8
Maximum age (years): 17
Standard ages: CHILD
Accepts healthy volunteers: yes
Observational model: CASE_CONTROL
Time perspective: PROSPECTIVE
Sampling method: NON_PROBABILITY_SAMPLE
Study population: Subjects with a diagnosis of nutrition and eating disorder, particularly anorexia nervosa, bulimia nervosa, binge eating disorder, according to the criteria of the Diagnostic and Statistical Manual of Mental Disorders DSM-5

Brief summary: Although eating disorders often occur during or after puberty, it is likely that critical antecedent conditions can be established before adolescence. The Eating Disorder Examination has been adapted for children and is described by Bryant - Waugh, Cooper, Taylor and Lask (1996). The EDE is considered the gold standard of measures of eating disorder psychopathology (Wilson, 1993), and this adaptation, which allows its use with a younger age group, is a potentially important addition to the assessment of eating disorders in children. The latest version of EDE, the l7th edition, has now surpassed its predecessors.

The aim of the study is to evaluate the psychometric properties of the Child vers ion EDE (chEDE) translated into Italian, in a sample of patients with eating disorder


Eligibility criteria: Inclusion Criteria:

* Subjects meet a diagnosis of nutrition and eating disorder, specifically anorexia nervosa, bulimia nervosa, binge eating disorder, according to the criteria of the Diagnostic and Statistical Manual of Mental Disorders DSM-5
* or (for control group) Exclusion of a current or past eating disorder by performing pre-testing (KL subscales - SADS) and BMI 17.5
* Signed informed consent

Exclusion Criteria:

* Schizophrenia or other psychotic disorders;
* Substance misuse in place
* Medical complications that have the potential to hinder interpretation of results ( e.g., a medical illness that induces weight loss)
* Presence of physical treatments (including medications) that have the potential to hinder interpretation of results (e.g., chemotherapy for cancer)
* or (for control group) Presence of a current or past eating disorder and/or Ongoing eating disorder therapy

Primary outcomes:
measure: K-SADS-PL (Kiddie-Schedule for Affective Disorder and Schizophrenia-Present and Lifetime version) questionnaire
timeFrame: Immediately after the end of the study (last subject who will complete the qestionnaire)
measure: ChEDE (Child Version of the EatingDisorder Examination)
timeFrame: Immediately after the end of the study (last subject who will complete the qestionnaire)
Secondary outcomes:
Other outcomes:
Locations:
city: Firenze
country: Italy
facility: Meyer Children's Hospital IRCCS
city: Firenze
country: Italy
facility: USL Toscana Centro
city: Garda
country: Italy
facility: Ospedale Villa Garda
Study officials:
References: